3M WP
Innovent Biologics begins subject dosing in plaque psoriasis therapy trial
The trial will assess the safety and efficacy of picankibart in moderate-to-severe plaque psoriasis patients.
BMJ finds 96% of oncology drug developers inadequately include minority groups
Kira gets clearance for bifunctional biologic trial in China, Australia
Biosimilars hit a turning point as they expand outside oncology
Vial adds NEXT Oncology to preferred site network
Running low on comparators: navigating drug shortages in oncology clinical trials
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
